A retrospective study of the incidence of post-acute SARS-CoV-2 sequelae (PASC) and mortality among vaccinated individuals in Alabama
Latest Information Update: 15 Dec 2022
At a glance
- Drugs Ad26.COV2 S (Primary) ; Elasomeran (Primary) ; Tozinameran (Primary)
- Indications COVID 2019 infections
- Focus Adverse reactions
Most Recent Events
- 15 Dec 2022 New trial record
- 07 Nov 2022 Results presented at the American Heart Association Scientific Sessions 2022